Insider Holders & Insider Ownership - REGENERON PHARMACEUTICALS INC. (REGN)

List of insiders holdings for REGENERON PHARMACEUTICALS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1SCHLEIFER LEONARD S
Bd. Co-Chair, President & CEO
2024-06-13 16:01:192,177,667
178,259
2,355,926Form 4
2YANCOPOULOS GEORGE
Bd. Co-Chair, President & CSO
2024-06-12 16:10:49868,994
241,951
1,110,945Form 4
3VAGELOS P ROY
Director
2023-04-05 16:02:23312,578
154,526
467,104Form 4
4SANOFI-AVENTIS
Sanofi-Aventis Amerique du Nord S.N.C.
10% Owner
2020-06-17 17:10:15279,766
0
279,766Form 13D
5Sanofi
10% Owner
2020-06-17 17:10:15279,766
0
279,766Form 13D
6GOLDBERG MURRAY A
SVP Administration & Asst Secr
2014-12-18 16:25:06142,515
6,400
148,915Form 4
7RUPP RANDALL
SVP, Manufuring Operations
2007-04-17 14:25:18142,137
0
142,137Form 4
8ROBERTS WILLIAM
VP Reg Dev & Med Safety
2014-02-06 16:41:1816,644
55,634
72,278Form 5
9GULER HANS PETER
VP Clinical Programs
2004-10-12 12:02:0867,152
0
67,152Form 4
10STAHL NEIL
EVP Research and Development
2024-12-18 16:02:5948,829
10,454
59,283Form 4
11MURPHY ANDREW J
EVP Research
2024-12-18 16:02:3449,074
4,326
53,400Form 4
12LAROSA JOSEPH J
EVP General Counsel and Secret
2024-12-18 16:01:5130,075
9,371
39,446Form 4
13Van Plew Daniel P
EVP & General Mgr, Industrial
2024-12-18 16:03:1134,792
1,100
35,892Form 4
14Landry Robert E
EVP Finance CFO
2024-02-06 16:08:1735,480
270
35,750Form 4
15Powchik Peter
SVP Clinical Development & Reg
2016-12-19 16:15:0630,714
4,133
34,847Form 4
16Terifay Robert J
EVP Commercial
2017-12-13 16:52:2932,300
0
32,300Form 4
17SING GEORGE L
Director
2025-01-03 16:02:2829,786
2,150
31,936Form 4
18Dworkin Peter
VP Investor Relations & Commun
2009-12-22 11:21:1323,500
0
23,500Form 4
19SHOOTER ERIC M
Director
2014-02-13 19:38:0915,000
5,085
20,085Form 4
20KOLINSKI STUART
SVP General Counsel and Secret
2010-06-07 16:14:1016,329
3,710
20,039Form 4
21Aberman Michael S
SVP Strategy Investor Relation
2017-06-23 16:10:087,693
12,253
19,946Form 4
22Fenimore Christopher R.
SVP Finance & CFO
2024-12-18 16:01:2016,265
3,462
19,727Form 4
23RYAN ARTHUR F
Director
2025-01-06 16:08:2719,706
0
19,706Form 4
24INGRAM ROBERT ALEXANDER
Director
2015-05-27 16:02:3514,833
0
14,833Form 4
25BROWN MICHAEL S
Director
2025-01-06 16:05:223,506
11,162
14,668Form 4
26McCourt Marion
EVP Commercial
2024-12-18 16:02:0714,230
174
14,404Form 4
27McCorkle Douglas S
VP Controller and Asst Treasur
2015-12-29 19:44:106,866
4,129
10,995Form 4
28GILMAN ALFRED G
Director
2015-08-07 18:15:048,912
0
8,912Form 4
29GOLDSTEIN JOSEPH L
Director
2025-01-06 16:06:048,506
0
8,506Form 4
30BAKER CHARLES A
Director
2018-01-03 16:14:217,439
0
7,439Form 4
31Pitofsky Jason
VP Controller
2024-12-18 16:02:484,664
190
4,854Form 4
32Tessier-Lavigne Marc
Director
2023-01-05 16:16:354,363
0
4,363Form 4
33POON CHRISTINE A
Director
2025-01-06 16:07:404,310
0
4,310Form 4
34COLES N ANTHONY
Director
2025-01-06 16:12:143,517
0
3,517Form 4
35Bassler Bonnie L
Director
2025-01-06 16:04:093,506
0
3,506Form 4
36Zoghbi Huda Y
Director
2025-01-06 16:11:473,506
0
3,506Form 4
37Thompson Craig B.
Director
2025-01-06 16:13:032,578
0
2,578Form 4
38Schenkein David P
Director
2025-01-06 17:42:192,406
0
2,406Form 4
39Guarini Kathryn
Director
2025-01-06 16:06:552,406
0
2,406Form 4
40NOVARTIS PHARMA AG
10% Owner
2005-11-10 14:56:080
0
0Form 13G